Breaking News Instant updates and real-time market news.

RAD

Rite Aid

$0.81

-0.0374 (-4.40%)

16:16
12/19/18
12/19
16:16
12/19/18
16:16

Rite Aid reports Q3 adjusted EPS 1c, consensus 0c

Reports Q3 revenue $5.5B, consensus $5.45B. Same store sales from Retail Pharmacy continuing operations for the quarter increased 1.6 percent compared to the prior year, consisting of a 3.1 percent increase in pharmacy sales and 1.5 percent decrease in front-end sales. Pharmacy sales included an approximate 108 basis point negative impact from new generic introductions. The number of prescriptions filled in same stores, adjusted to 30-day equivalents, increased 2.4 percent compared to the prior year period due to strong results from immunizations and other initiatives to drive script growth. Prescription sales from continuing operations accounted for 67.6 percent of total drugstore sales.

  • 19

    Dec

RAD Rite Aid
$0.81

-0.0374 (-4.40%)

09/28/18
LOOP
09/28/18
NO CHANGE
Target $1.35
LOOP
Hold
Rite Aid price target lowered to $1.35 at Loop Capital on Albertsons deal
Loop Capital analyst Andrew Wolf lowered his price target on Rite Aid to $1.35 from $1.75 and kept his Hold rating after its Q2 results, saying that while the Pharmacy Services segment showed improved sales profitability, this was offset by lower profitability in Retail Pharmacy. The analyst added that the discount on the Rite Aid stock relative to the broader pharmacy group is "appropriate" given its "high debt leverage and subscale operations". Wolf further notes that the board's caving to shareholder pressure to cancel the Albertsons deal was a mistake directly linked to the 28% decline in the stock price since August 8th.
10/12/18
RHCO
10/12/18
NO CHANGE
Target $75
RHCO
Hold
Walgreens Boots Alliance price target raised to $75 from $66 at SunTrust
SunTrust analyst David MacDonald raised his price target on Walgreens Boots Alliance (WBA) to $75 after its Q4 earnings beat and FY19 guidance yesterday. The analyst says the results were marked by "solid U.S. pharmacy performance" in spite of the ongoing reimbursement and generic headwinds. MacDonald also keeps his Hold rating, adding that while the company's cash flow remains "robust" and the integration of Rite Aid (RAD) is still on track, he is concerned about the challenging environment and ongoing degradation in gross margins.
11/19/18
JEFF
11/19/18
NO CHANGE
JEFF
Jefferies uncovers signs of Amazon expanding prescription drug presence
Jefferies analyst Brian Tanquilut says his proprietary checks of Amazon.com's (AMZN) moves in the pharmacy space indicate that the online retailer has finally made moves to expand PillPack. However, the initial expansion phase appears focused on offering pharmacy services to Amazon employees in Washington. In his most recent webscrape, Tanquilut came across a new prescription license in WA, two pending Rx licenses in New Mexico and Indiana, and pharmacy technician and packaging/shipping job postings all linked to PillPack's Phoenix facility. These new developments signal the beginning of Amazon's prescription expansion via PillPack, Tanquilut tells investors in a research note. If Amazon were to rollout a more extensive PillPack offering to its own employee base, Rite Aid (RAD) could be most exposed to potential script transfers with Walgreens Boots Alliance (WBA) the least exposed among the public drugstores, says the analyst. He still believes that the impact of Amazon's pharmacy entry will take a while to materialize for drug stores CVS Health (CVS) and Walgreens.
12/14/18
GSCO
12/14/18
DOWNGRADE
Target $68
GSCO
Sell
Goldman downgrades Walgreens to Sell with $68 target, sees downside in 2019
Goldman Sachs analyst Robert Jones downgraded Walgreens Boots Alliance (WBA) to Sell from Neutral and lowered his price target for the shares to $68 from $73. The analyst says he struggles to make a "compelling fundamental case" for the Americas Healthcare Services Supply Chain heading into 2019 as "issues facing core growth drivers do not seem to be abating." Jones sees limited "core" growth for the large-cap names amid persisting sales and margin pressures and as drug pricing remains a regulatory focus. He downgrades Walgreens to Sell saying challenges in its retail pharmacy business "have intensified, forcing the company to search for other avenues of growth." Jones also keeps a Neutral rating on CVS Health (CVS) and Sell rating on Rite Aid (RAD).

TODAY'S FREE FLY STORIES

RHHBY

Roche

$0.00

(0.00%)

05:21
10/14/19
10/14
05:21
10/14/19
05:21
Hot Stocks
Genentech says Phase III PEMPHIX study met primary endpoint »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 06

    Nov

INCY

Incyte

$76.14

0.38 (0.50%)

05:16
10/14/19
10/14
05:16
10/14/19
05:16
Recommendations
Incyte analyst commentary  »

Incyte data enchances…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

MELI

MercadoLibre

$554.23

11.5 (2.12%)

05:11
10/14/19
10/14
05:11
10/14/19
05:11
Recommendations
MercadoLibre analyst commentary  »

MercadoLibre positioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 17

    Dec

PLNT

Planet Fitness

$58.63

0.94 (1.63%)

05:09
10/14/19
10/14
05:09
10/14/19
05:09
Upgrade
Planet Fitness rating change  »

Planet Fitness upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:06
10/14/19
10/14
05:06
10/14/19
05:06
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

05:05
10/14/19
10/14
05:05
10/14/19
05:05
Upgrade
LeMaitre rating change  »

LeMaitre upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

05:03
10/14/19
10/14
05:03
10/14/19
05:03
Initiation
IGM Biosciences initiated  »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DDOG

Datadog

$35.67

0.08 (0.22%)

05:01
10/14/19
10/14
05:01
10/14/19
05:01
Initiation
Datadog initiated  »

Datadog initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PING

Ping Identity

$16.47

0.45 (2.81%)

04:58
10/14/19
10/14
04:58
10/14/19
04:58
Initiation
Ping Identity initiated  »

Ping Identity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NVST

Envista

$27.87

-1.2 (-4.13%)

04:57
10/14/19
10/14
04:57
10/14/19
04:57
Initiation
Envista initiated  »

Envista initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$124.41

0.98 (0.79%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Downgrade
Mohawk rating change  »

Mohawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

KBH

KB Home

$33.92

-0.15 (-0.44%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
UBS technology analyst to hold an analyst/industry conference call »

Technology Analyst…

ZLAB

Zai Lab

$32.38

0.01 (0.03%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Zai Lab participates in a conference call with JPMorgan »

SMid Biotechnology Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

SAN

Banco Santander

$4.10

0.155 (3.93%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Banco Santander management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Evercore REITs analyst to hold a luncheon »

REITs Analyst Sakwa holds…

WORK

Slack Technologies

$25.99

2.215 (9.32%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Slack Technologies management to meet with »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

MDLA

Medallia

$29.47

1.365 (4.86%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Medallia management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

CRNCY

Cairn Energy

$0.00

(0.00%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
Cairn Energy management to meet with Bergenberg »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

  • 16

    Oct

NXTC

NextCure

$27.19

1.26 (4.86%)

04:55
10/14/19
10/14
04:55
10/14/19
04:55
Conference/Events
NextCure management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 15

    Oct

  • 16

    Oct

FAST

Fastenal

$36.36

5.35 (17.25%)

04:54
10/14/19
10/14
04:54
10/14/19
04:54
Downgrade
Fastenal rating change  »

Fastenal downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PING

Ping Identity

$16.47

0.45 (2.81%)

04:51
10/14/19
10/14
04:51
10/14/19
04:51
Initiation
Ping Identity initiated  »

Ping Identity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PING

Ping Identity

$16.47

0.45 (2.81%)

04:50
10/14/19
10/14
04:50
10/14/19
04:50
Initiation
Ping Identity initiated  »

Ping Identity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NTES

NetEase

$269.12

10.13 (3.91%)

04:48
10/14/19
10/14
04:48
10/14/19
04:48
Downgrade
NetEase rating change  »

NetEase downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.